Fulcrum Therapeutics Inc. (FULC) at a glance

Fulcrum Therapeutics Inc. (FULC) is a micro-cap Healthcare company. It trades at $3.82, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 40/100 overall. Its strongest dimension is Value (58/100) and its weakest is Safety (14/100). It carries above-market volatility, so expect larger swings.

Price

$3.82

Market cap

$229.9M

P/E ratio

n/a

Dividend yield

None

Beta

2.92

52-week range

$2.83 to $15.74